Artículos por temáticas

Spatiotemporal gait characteristics of Huntington's disease during dual-task walking.

Radovanović S, Vodopić S, Stanković I, Dragašević-Mišković N, Kostić V.

Int J Neurosci. 2019 Oct 2:1-8. doi: 10.1080/00207454.2019.1667781. [Epub ahead of print]

Self-organizing neuruloids model developmental aspects of Huntington's disease in the ectodermal compartment.

Haremaki T, Metzger JJ, Rito T, Ozair MZ, Etoc F, Brivanlou AH.

Nat Biotechnol. 2019 Oct;37(10):1198-1208. doi: 10.1038/s41587-019-0237-5. Epub 2019 Sep 9.

Huntington's disease patients display progressive deficits in hippocampal-dependent cognition during a task of spatial memory.

Harris KL, Armstrong M, Swain R, Erzinclioglu S, Das T, Burgess N, Barker RA, Mason SL.

Cortex. 2019 Oct;119:417-427. doi: 10.1016/j.cortex.2019.07.014. Epub 2019 Aug 13.

Increased translation as a novel pathogenic mechanism in Huntington's disease.

Creus-Muncunill J, Badillos-Rodríguez R, Garcia-Forn M, Masana M, Garcia-Díaz Barriga G, Guisado-Corcoll A, Alberch J, Malagelada C, Delgado-García JM, Gruart A, Pérez-Navarro E.

Brain. 2019 Oct 1;142(10):3158-3175. doi: 10.1093/brain/awz230.

Sleep in Huntington's disease: a systematic review and meta-analysis of polysomongraphic findings.

Zhang Y, Ren R, Yang L, Zhou J, Li Y, Shi J, Lu L, Sanford LD, Tang X.

Sleep. 2019 Oct 9;42(10). pii: zsz154. doi: 10.1093/sleep/zsz154.

Quality Control in Huntington's Disease: a Therapeutic Target.

Rai SN, Singh BK, Rathore AS, Zahra W, Keswani C, Birla H, Singh SS, Dilnashin H, Singh SP.

Neurotox Res. 2019 Oct;36(3):612-626. doi: 10.1007/s12640-019-00087-x. Epub 2019 Jul 11. Review.

Clinicopathological differences between the motor onset and psychiatric onset of Huntington's disease, focusing on the nucleus accumbens.

Hirano M, Iritani S, Fujishiro H, Torii Y, Habuchi C, Sekiguchi H, Yoshida M, Ozaki N.

Neuropathology. 2019 Oct;39(5):331-341. doi: 10.1111/neup.12578. Epub 2019 Jul 2.

Network spread determines severity of degeneration and disconnection in Huntington's disease.

Poudel GR, Harding IH, Egan GF, Georgiou-Karistianis N.

Hum Brain Mapp. 2019 Oct 1;40(14):4192-4201. doi: 10.1002/hbm.24695. Epub 2019 Jun 12.

Lowering Mutant Huntingtin Using Tricyclo-DNA Antisense Oligonucleotides As a Therapeutic Approach for Huntington's Disease.

Imbert M, Blandel F, Leumann C, Garcia L, Goyenvalle A.

Nucleic Acid Ther. 2019 Oct;29(5):256-265. doi: 10.1089/nat.2018.0775. Epub 2019 Jun 11.

Emerging therapies in Huntington's disease.

Bashir H.

Expert Rev Neurother. 2019 Oct;19(10):983-995. doi: 10.1080/14737175.2019.1631161. Epub 2019 Jun 17.

Can leukocyte telomere shortening be a possible biomarker to track Huntington's disease progression?

Mantuano E, Peconi M, Scarabino D.

Neural Regen Res. 2019 Oct;14(10):1709-1710. doi: 10.4103/1673-5374.257522. No abstract available.

'Real-life' hippocampal-dependent spatial memory impairments in Huntington's disease.

Glikmann-Johnston Y, Carmichael AM, Mercieca EC, Stout JC.

Cortex. 2019 Oct;119:46-60. doi: 10.1016/j.cortex.2019.04.006. Epub 2019 Apr 15.

Impaired Remyelination in a Mouse Model of Huntington Disease.

Teo RTY, Ferrari Bardile C, Tay YL, Yusof NABM, Kreidy CA, Tan LJ, Pouladi MA.

Mol Neurobiol. 2019 Oct;56(10):6873-6882. doi: 10.1007/s12035-019-1579-1. Epub 2019 Apr 2.

Non-coding RNA Neat1 and Abhd11os expressions are dysregulated in medium spiny neurons of Huntington disease model mice.

Park H, Miyazaki H, Yamanaka T, Nukina N.

Neurosci Res. 2019 Oct;147:58-63. doi: 10.1016/j.neures.2018.10.013. Epub 2018 Nov 2.

Generation of induced Pluripotent Stem Cells (UNIBSi008-A, UNIBSi008-B, UNIBSi008-C) from an Ataxia-Telangiectasia (AT) patient carrying a novel homozygous deletion in ATM gene.

Masneri S, Ferraro RM, Lanzi G, Piovani G, Mori L, Barisani C, Moratto D, Plebani A, Badolato R, Soresina A, Giliani S.

Stem Cell Res. 2019 Oct 18;41:101596. doi: 10.1016/j.scr.2019.101596. [Epub ahead of print]